Skip to main content
Clinical Trials/NCT06322615
NCT06322615
Completed
Not Applicable

Acupressure for Anxiety: A Pilot Study of a Nurse-Led Acupressure Intervention for Patients Receiving Chemotherapy

Mayo Clinic1 site in 1 country30 target enrollmentAugust 8, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hematopoietic and Lymphatic System Neoplasm
Sponsor
Mayo Clinic
Enrollment
30
Locations
1
Primary Endpoint
Time taken for each nurse-led acupressure intervention in the chemotherapy unit (Feasibility)
Status
Completed
Last Updated
6 months ago

Overview

Brief Summary

This clinical trial evaluates whether acupressure is helpful to reduce anxiety related to chemotherapy. Anxiety is experienced by many patients with cancer. Anxiety can be related to chemotherapy and may contribute to other symptoms, such as nausea and poor quality of life. Some patients diagnosed with cancer express interest in non-medicinal ways to manage symptoms. Acupressure is a noninvasive intervention that can be used for many different symptoms. Acupressure is well tolerated with minimal reports of adverse reactions, making it a good choice for patients with cancer. This study may help researchers learn whether acupressure is useful for managing anxiety in patients undergoing chemotherapy.

Detailed Description

PRIMARY OBJECTIVES: I. Evaluate the feasibility of a nurse- and patient-applied acupressure intervention for patients with anxiety associated with active cancer-directed therapy. II. Patient-reported changes in acute anxiety associated with both the nurse and self-led acupressure interventions will be ascertained. OUTLINE: Patients undergo acupressure over 15-120 seconds at a time for up to 15 minutes. After completion of the session, patients may optionally receive an education session on using acupressure at home. After completion of study intervention, patients who opted to receive education about using acupressure at home are followed up at 1 week.

Registry
clinicaltrials.gov
Start Date
August 8, 2023
End Date
February 1, 2024
Last Updated
6 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Be over 18 years of age
  • Be actively undergoing chemotherapy in the Mayo Clinic chemotherapy unit
  • Report anxiety as a 1 or higher, on a scale from 0 (no anxiety) to 4 (severe anxiety)
  • Be willing to undergo a short acupressure session

Exclusion Criteria

  • Does not meet the inclusion criteria

Outcomes

Primary Outcomes

Time taken for each nurse-led acupressure intervention in the chemotherapy unit (Feasibility)

Time Frame: Up to 1 year

Assess by the time recorded for ach nurse-led acupressure intervention in the chemotherapy unit.

Number of patients approached about undergoing acupressure intervention (Feasibility)

Time Frame: Up to 1 year

Assessed by the number of patients approached about undergoing acupressure intervention.

Patient-reported changes in acute anxiety

Time Frame: At baseline, after a one-time nurse-administered acupressure session, and after one week of self-administered acupressure sessions

Assessed with a brief anxiety questionnaire that inquires about the three different domains of anxiety: cognitive symptoms, emotional symptoms, and physical symptoms. Seven questions are answered using 11-point (0-10) scales with different values assigned to the scale per question (e.g. 0=no anxiety/10=worst possible anxiety or 0=strongly disagree/10=strongly agree).

Number of patients interested in the initial acupressure intervention in the chemotherapy unit (Feasibility)

Time Frame: Up to 1 year

Assessed by the number of patients who express interest in the initial acupressure intervention in the chemotherapy unit.

Number of patients interested in the home acupressure intervention (Feasibility)

Time Frame: Up to 1 year

Assessed by the number of patients who express interest in the home acupressure intervention.

Study Sites (1)

Loading locations...

Similar Trials